News and events
closerlook named one of top 100 agencies
Medical Marketing & Media - July 2016
We’re honored to announce that closerlook has once again been named a Medical Marketing & Media (MM&M) Top 100 Agency in 2016. CEO David Ormesher and CCO Ryan Mason recently spoke with MM&M about our work over the past year, and our vision for the future.
“We're going to look back at 2015 as the year that pharma stopped talking about multi-channel marketing and started embracing it in a meaningful way,” Ormesher told MM&M.
That means future marketing will be driven ever more by real-time analytics, allowing closerlook to act as a partner in helping marketers make effective, data-driven decisions. Mason underscored the importance of being able to truly evaluate multi-channel marketing constantly, telling MM&M, “It's becoming the center of marketing-ops groups and crucial to centers of excellence around digital marketing.”
closerlook’s Target Clarity® Healthcare Adoption Analysis Offering
This has spurred a deeper investment in both analytics and strategy capabilities as closerlook continues to build offerings that can deliver across multiple channels and be created wholly in-house.
Ormesher believes the pairing of smarter analytics with multichannel marketing will continue to act as a key differentiator for closerlook.
The profile also discusses closerlook’s 35% revenue growth in 2015. This resulted in a 25-person jump in headcount to 150 employees, as well as some key internal promotions to ensure clients continue to get the best service and expertise in the industry from closerlook.
Read MM&M profile
The drugs, Optistavin, Easovartis and Librylin, and names, results, case studies and specific information, referenced in this advertisement are fictional and were created solely for illustrating the digital marketing capabilities of closerlook, inc. Any resemblance to actual drugs, medications, treatments, persons, living or dead, or to actual events, is purely coincidental. closerlook, inc. does not assume and hereby disclaims any liability to any party for any loss, damage or disruption caused by such party’s reliance on the fictitious information contained in this illustration.